江蘇省藥物研究所有限公司，始建于1962 年7 月，隸屬于江蘇省衛(wèi)生廳、江蘇省科技廳，2006年12月，整體合并進入南京工業(yè)大學。是專門從事新藥創(chuàng)制與開發(fā)研究的專業(yè)科研機構(gòu)，江蘇省新藥臨床前研究基地，國家新藥臨床前安全評價中心，國家高新技術(shù)企業(yè)。江蘇省藥物研究所一直致力于新藥研制開發(fā)，獲國家新藥證書168份。新藥成果轉(zhuǎn)化率達98%以上。累計為相關(guān)合作企業(yè)創(chuàng)造產(chǎn)值256億元。

典型案例

●注射用紫杉醇脂質(zhì)體

●注射用兩性霉素B脂質(zhì)體 

●依托泊苷軟膠囊（江蘇恒瑞）

Jiangsu Provincial Institute of Materia Medica Co.Ltd, was founded in July 1962, was affiliated to the Jiangsu Provincial Department of Health and the Jiangsu Provincial Science and Technology Department. In December 2006, the company merged into Nanjing Technology University. As a professional scientific research institution specializing in the drug discovery and drug development, the company is a Center for Preclinical Study for New Drugs of Jiangsu Province, a National Preclinical Safety Evaluation Center for New Drugs, and a National High-tech Enterprise.

Jiangsu Provincial Institute of Materia Medica Co.Ltd has been committed to the new drug discovery and development, and has obtained 168 national new drug certificates. The conversion rate of new drug achievements has reached more than 98%. The total output value of relevant cooperative enterprises has been 25.6 billion yuan.

Examples Insights

●Paclitaxel liposomes

●Amphotericin B liposomes for injection

●Etoposide Softgels（Jiangsu Hengrui Pharmaceutical Co., Ltd.）